15.1
Novartis AG Sponsored ADR
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
14.2
FY23:
14.5
FY24:
17.6
FY25:
19.1
Change from FY21 to FY25
billions USD
FY21:
4.21
FY22:
1.47
FY23:
5.60
FY24:
−7.51
FY25:
−4.88
Change from FY21 to FY25
billions USD
FY21:
−16.3
FY22:
−20.6
FY23:
−14.3
FY24:
−11.7
FY25:
−14.9
billions USD
FY21:
2.75
FY22:
−4.89
FY23:
5.88
FY24:
−1.93
FY25:
−0.02
(positive)
Change from FY21 to FY25
billions USD
FY21:
14.0
FY22:
13.3
FY23:
13.4
FY24:
16.3
FY25:
17.6
All amounts in billions USD